Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P McCormack

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|December 29, 2000
An emotional-based medicine approach to monitoring once-daily aminoglycosidesJ P McCormack
DICP : the Annals of Pharmacotherapy|July 1, 1989
Comment: impact of a kinetic service on aminoglycoside patientsJ P McCormack
The Annals of Pharmacotherapy|October 1, 1993
Meaningful interpretation of risk reduction from clinical drug trialsJ P McCormack, M Levine
Pharmacotherapy|December 17, 1997
A simpler approach to pharmacokinetic dosage adjustmentsJ P McCormack, B Carleton
Intensive Care Medicine|January 1, 1994
Determination of the optimum timing for pharmacokinetic monitoring of once daily aminoglycoside dosingG Brown, J P McCormack
DICP : the Annals of Pharmacotherapy|September 1, 1989
Comment: unusual digoxin concentrationsM Levine, J P McCormack
American Journal of Hospital Pharmacy|December 1, 1992
Disagreement with liability for failure to monitor serum gentamicin concentrationsJ P McCormack, G R Brown
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1992
A critical reevaluation of the "therapeutic range" of aminoglycosidesJ P McCormack, P J Jewesson
Drug Intelligence & Clinical Pharmacy|February 1, 1987
Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimensJ P McCormack, J J Schentag
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 14, 1997
Simple approach to dosage adjustment in patients with renal impairmentJ P McCormack, J Cooper, B Carleton
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|December 29, 2000
An emotional-based medicine approach to monitoring once-daily aminoglycosidesJ P McCormack
DICP : the Annals of Pharmacotherapy|July 1, 1989
Comment: impact of a kinetic service on aminoglycoside patientsJ P McCormack
The Annals of Pharmacotherapy|October 1, 1993
Meaningful interpretation of risk reduction from clinical drug trialsJ P McCormack, M Levine
Pharmacotherapy|December 17, 1997
A simpler approach to pharmacokinetic dosage adjustmentsJ P McCormack, B Carleton
Intensive Care Medicine|January 1, 1994
Determination of the optimum timing for pharmacokinetic monitoring of once daily aminoglycoside dosingG Brown, J P McCormack
DICP : the Annals of Pharmacotherapy|September 1, 1989
Comment: unusual digoxin concentrationsM Levine, J P McCormack
American Journal of Hospital Pharmacy|December 1, 1992
Disagreement with liability for failure to monitor serum gentamicin concentrationsJ P McCormack, G R Brown
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1992
A critical reevaluation of the "therapeutic range" of aminoglycosidesJ P McCormack, P J Jewesson
Drug Intelligence & Clinical Pharmacy|February 1, 1987
Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimensJ P McCormack, J J Schentag
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 14, 1997
Simple approach to dosage adjustment in patients with renal impairmentJ P McCormack, J Cooper, B Carleton
Pageof 3